ARMATA PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Basic Shares Outstanding (Weighted Average) of 36.75 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 36.75M shares, a 1.53% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 36.53M shares, a 0.95% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 36.35M shares, a 0.47% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 36.23M shares, a 0.13% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 36.24M shares, a 0.22% increase from fiscal 2024.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 36.16M shares, a 0.24% increase from fiscal 2023.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 36.08M shares, a 5.19% increase from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 34.29M shares, a 42.27% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 36.75M shares 10-Q · filed 2026-08-12 | 36.64M shares 10-Q · filed 2026-08-12 | 36.54M shares derived: average of 3 quarters · filed 2026-08-12 | 36.46M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 36.53M shares 10-Q · filed 2026-05-13 | 36.44M shares derived: average of 2 quarters · filed 2026-05-13 | 36.37M shares derived: average of 3 quarters · filed 2026-05-13 | 36.33M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | 36.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 36.29M shares derived: average of 2 quarters · filed 2026-03-25 | 36.26M shares derived: average of 3 quarters · filed 2026-08-12 | 36.24M shares 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | 36.23M shares 10-Q · filed 2025-11-12 | 36.21M shares derived: average of 2 quarters · filed 2026-08-12 | 36.20M shares 10-Q · filed 2025-11-12 | 36.20M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 36.19M shares 10-Q · filed 2026-08-12 | 36.19M shares 10-Q · filed 2026-08-12 | 36.19M shares derived: average of 3 quarters · filed 2026-08-12 | 36.19M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | 36.18M shares 10-Q · filed 2026-05-13 | 36.18M shares derived: average of 2 quarters · filed 2026-05-13 | 36.18M shares derived: average of 3 quarters · filed 2026-05-13 | 36.18M shares derived: average of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | 36.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 36.18M shares derived: average of 2 quarters · filed 2026-03-25 | 36.17M shares derived: average of 3 quarters · filed 2026-03-25 | 36.16M shares 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | 36.18M shares 10-Q · filed 2025-11-12 | 36.17M shares derived: average of 2 quarters · filed 2025-11-12 | 36.15M shares 10-Q · filed 2025-11-12 | 36.14M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 36.15M shares 10-Q · filed 2025-08-12 | 36.14M shares 10-Q · filed 2025-08-12 | 36.13M shares derived: average of 3 quarters · filed 2025-08-12 | 36.12M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 36.12M shares 10-Q · filed 2025-05-14 | 36.11M shares derived: average of 2 quarters · filed 2025-05-14 | 36.10M shares derived: average of 3 quarters · filed 2025-05-14 | 36.10M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 36.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 36.09M shares derived: average of 2 quarters · filed 2025-03-21 | 36.09M shares derived: average of 3 quarters · filed 2025-03-21 | 36.08M shares 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | 36.09M shares 10-Q · filed 2024-11-13 | 36.08M shares derived: average of 2 quarters · filed 2024-11-13 | 36.07M shares 10-Q · filed 2024-11-13 | 36.07M shares derived: average of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 36.07M shares 10-Q · filed 2024-08-13 | 36.06M shares 10-Q · filed 2024-08-13 | 36.06M shares derived: average of 3 quarters · filed 2024-08-13 | 36.05M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 36.05M shares 10-Q · filed 2024-05-07 | 36.05M shares derived: average of 2 quarters · filed 2024-05-07 | 36.05M shares derived: average of 3 quarters · filed 2024-05-07 | 36.04M shares derived: average of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | 36.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 36.05M shares derived: average of 2 quarters · filed 2024-03-21 | 36.03M shares derived: average of 3 quarters · filed 2024-03-21 | 34.29M shares 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | 36.04M shares 10-Q · filed 2023-11-14 | 36.02M shares derived: average of 2 quarters · filed 2023-11-14 | 33.70M shares 10-Q · filed 2023-11-14 | 31.84M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 36.00M shares 10-Q · filed 2023-08-14 | 32.52M shares 10-Q · filed 2023-08-14 | 30.44M shares derived: average of 3 quarters · filed 2023-08-14 | 29.04M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 29.00M shares 10-Q · filed 2023-05-11 | 27.66M shares derived: average of 2 quarters · filed 2023-05-11 | 26.71M shares derived: average of 3 quarters · filed 2023-05-11 | 26.23M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 26.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 25.57M shares derived: average of 2 quarters · filed 2023-03-16 | 25.30M shares derived: average of 3 quarters · filed 2023-03-16 | 24.10M shares 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | 24.82M shares 10-Q · filed 2022-11-09 | 24.79M shares derived: average of 2 quarters · filed 2022-11-09 | 23.36M shares 10-Q · filed 2022-11-09 | 22.12M shares derived: average of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | 24.76M shares 10-Q · filed 2022-08-11 | 22.62M shares 10-Q · filed 2022-08-11 | 21.22M shares derived: average of 3 quarters · filed 2022-08-11 | 20.51M shares derived: average of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | 20.46M shares 10-Q · filed 2022-05-12 | 19.45M shares derived: average of 2 quarters · filed 2022-05-12 | 19.10M shares derived: average of 3 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | 18.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 18.42M shares derived: average of 2 quarters · filed 2022-03-17 | 16.42M shares 10-K · filed 2022-03-17 | |||||
| 2020-09-30 | 18.39M shares 10-Q · filed 2020-11-12 | 15.74M shares 10-Q · filed 2020-11-12 | ||||||
| 2019-12-31 | 9.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 9.55M shares derived: average of 2 quarters · filed 2021-03-18 | 8.87M shares derived: average of 3 quarters · filed 2021-03-18 | 7.83M shares 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | 9.55M shares 10-Q · filed 2020-11-12 | 8.53M shares derived: average of 2 quarters · filed 2020-11-12 | 7.25M shares 10-Q · filed 2020-11-12 | 13.53M shares derived: average of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | 7.51M shares 10-Q · filed 2019-08-14 | 6.09M shares 10-Q · filed 2019-08-14 | 14.85M shares derived: average of 3 quarters · filed 2020-03-19 | 12.30M shares derived: average of 4 quarters · filed 2020-03-19 | ||||
| 2019-03-31 | 32.39M shares 10-Q · filed 2019-05-06 | 18.52M shares derived: average of 2 quarters · filed 2020-03-19 | 13.90M shares derived: average of 3 quarters · filed 2020-03-19 | 11.59M shares derived: average of 4 quarters · filed 2020-03-19 | ||||
| 2018-12-31 | 4.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 4.65M shares derived: average of 2 quarters · filed 2020-03-19 | 4.65M shares derived: average of 3 quarters · filed 2020-03-19 | 4.65M shares 10-K · filed 2020-03-19 | 18.98M shares 10-K · filed 2019-03-25 | |||
| 2018-09-30 | 4.65M shares 10-Q · filed 2019-11-12 | 16.47M shares 10-Q · filed 2018-11-08 | 4.65M shares derived: average of 2 quarters · filed 2019-11-12 | 4.65M shares 10-Q · filed 2019-11-12 | 15.42M shares 10-Q · filed 2018-11-08 | 8.04M shares derived: average of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | 4.65M shares 10-Q · filed 2019-08-14 | 16.46M shares 10-Q · filed 2018-08-09 | 4.65M shares 10-Q · filed 2019-08-14 | 14.89M shares 10-Q · filed 2018-08-09 | 9.17M shares derived: average of 3 quarters · filed 2019-08-14 | 9.10M shares derived: average of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | 13.30M shares 10-Q · filed 2019-05-06 | 11.43M shares derived: average of 2 quarters · filed 2019-05-06 | 10.58M shares derived: average of 3 quarters · filed 2019-05-06 | 9.27M shares derived: average of 4 quarters · filed 2019-05-06 | ||||
| 2017-12-31 | 9.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | 9.22M shares derived: average of 2 quarters · filed 2019-03-25 | 7.93M shares derived: average of 3 quarters · filed 2019-03-25 | 6.39M shares 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | 8.87M shares 10-Q · filed 2018-11-08 | 7.11M shares derived: average of 2 quarters · filed 2018-11-08 | 5.33M shares 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | 5.35M shares 10-Q · filed 2018-08-09 | 3.51M shares 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | 1.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 1.24M shares derived: average of 2 quarters · filed 2018-03-14 | 1.11M shares derived: average of 3 quarters · filed 2018-03-14 | 983.85K shares 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | 1.11M shares 10-Q · filed 2017-11-14 | 11.12M shares 10-Q · filed 2016-11-10 | 993.05K shares derived: average of 2 quarters · filed 2017-11-14 | 859.08K shares 10-Q · filed 2017-11-14 | 8.59M shares 10-Q · filed 2016-11-10 | 3.44M shares derived: average of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | 874.06K shares 10-Q · filed 2017-08-14 | 8.74M shares 10-Q · filed 2016-08-15 | 731.21K shares 10-Q · filed 2017-08-14 | 7.31M shares 10-Q · filed 2016-08-15 | 4.22M shares derived: average of 3 quarters · filed 2017-08-14 | 4.62M shares derived: average of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | 5.88M shares 10-Q · filed 2016-05-12 | 5.89M shares derived: average of 2 quarters · filed 2016-05-12 | 5.87M shares derived: average of 3 quarters · filed 2016-11-10 | 5.82M shares derived: average of 4 quarters · filed 2016-11-10 | ||||
| 2015-12-31 | 5.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 5.86M shares derived: average of 2 quarters · filed 2016-11-10 | 5.79M shares derived: average of 3 quarters · filed 2016-11-10 | 5.41M shares 10-K · filed 2016-03-30 | ||||
| 2015-09-30 | 5.81M shares 10-Q · filed 2016-11-10 | 5.74M shares derived: average of 2 quarters · filed 2016-11-10 | 5.25M shares 10-Q · filed 2016-11-10 | 4.91M shares derived: average of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | 5.67M shares 10-Q · filed 2016-08-15 | 4.96M shares 10-Q · filed 2016-08-15 | 4.61M shares derived: average of 3 quarters · filed 2016-08-15 | 4.39M shares derived: average of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | 4.25M shares 10-Q · filed 2016-05-12 | 4.08M shares derived: average of 2 quarters · filed 2016-05-12 | 3.97M shares derived: average of 3 quarters · filed 2016-05-12 | 3.90M shares derived: average of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | 3.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 3.83M shares derived: average of 2 quarters · filed 2016-03-30 | 3.78M shares derived: average of 3 quarters · filed 2016-03-30 | 3.75M shares 10-K · filed 2016-03-30 | 187.33M shares 10-K · filed 2015-04-15 | |||
| 2014-09-30 | 3.74M shares 10-Q · filed 2015-11-16 | 187.16M shares 10-Q · filed 2014-11-14 | 3.71M shares derived: average of 2 quarters · filed 2015-11-16 | 3.69M shares 10-Q · filed 2015-11-16 | 184.45M shares 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | 3.67M shares 10-Q · filed 2015-08-13 | 183.59M shares 10-Q · filed 2014-09-12 | 3.66M shares 10-Q · filed 2015-08-13 | 183.07M shares 10-Q · filed 2014-09-12 | ||||
| 2013-12-31 | 147.74M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-04-15 | 123.45M shares derived: average of 2 quarters · filed 2015-04-15 | 112.51M shares derived: average of 3 quarters · filed 2015-04-15 | 101.20M shares 10-K · filed 2015-04-15 | ||||
| 2013-09-30 | 99.16M shares 10-Q/A · filed 2015-04-15 | 94.90M shares derived: average of 2 quarters · filed 2015-04-15 | 85.69M shares 10-Q/A · filed 2015-04-15 | |||||
| 2013-06-30 | 90.65M shares 10-Q/A · filed 2015-04-15 | 78.84M shares 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |